Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D de Zeeuw

Showing results (71-80 of 223) with videos related to

Pageof 23
Sort By:
Renal Failure|May 9, 1998
Can continuous intraperitoneal infusion of 125I-iothalamate and 131I-hippuran be used for measurement of GFR in conscious rats?P A de Vries, G Navis, P E de Jong, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabeticsP E de Jong, J E Heeg, A J Apperloo, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1995
Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndromeD de Zeeuw, R T Gansevoort, R P Dullaart, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1983
The angiotensin converting enzyme inhibitor enalapril and its effects on renal functionD de Zeeuw, G J Navis, A J Donker, et al.
Diabetes, Obesity & Metabolism|May 15, 2013
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetesH J Lambers Heerspink, D de Zeeuw, L Wie, et al.
Renal Failure|May 9, 1998
Drug delivery to the kidneys and the bladder with the low molecular weight protein lysozymeR J Kok, M Haas, F Moolenaar, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Effects of enalapril on blood pressure and renal haemodynamics in essential hypertensionG J Navis, P E de Jong, A J Donker, et al.
Nephron|January 1, 1990
Lisinopril in hypertensive patients with renal function impairmentP E de Jong, A J Apperloo, J E Heeg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1991
Angiotensin-I converting enzyme inhibition: clinical effects in chronic renal diseaseP E de Jong, J E Heeg, A J Apperloo, et al.
European Journal of Clinical Investigation|December 3, 1999
Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertensionP van Paassen, G J Navis, P E De Jong, et al.
Pageof 23

Showing results (71-80 of 223) with videos related to

Sort By:
Pageof 23
Renal Failure|May 9, 1998
Can continuous intraperitoneal infusion of 125I-iothalamate and 131I-hippuran be used for measurement of GFR in conscious rats?P A de Vries, G Navis, P E de Jong, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabeticsP E de Jong, J E Heeg, A J Apperloo, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1995
Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndromeD de Zeeuw, R T Gansevoort, R P Dullaart, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1983
The angiotensin converting enzyme inhibitor enalapril and its effects on renal functionD de Zeeuw, G J Navis, A J Donker, et al.
Diabetes, Obesity & Metabolism|May 15, 2013
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetesH J Lambers Heerspink, D de Zeeuw, L Wie, et al.
Renal Failure|May 9, 1998
Drug delivery to the kidneys and the bladder with the low molecular weight protein lysozymeR J Kok, M Haas, F Moolenaar, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Effects of enalapril on blood pressure and renal haemodynamics in essential hypertensionG J Navis, P E de Jong, A J Donker, et al.
Nephron|January 1, 1990
Lisinopril in hypertensive patients with renal function impairmentP E de Jong, A J Apperloo, J E Heeg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1991
Angiotensin-I converting enzyme inhibition: clinical effects in chronic renal diseaseP E de Jong, J E Heeg, A J Apperloo, et al.
European Journal of Clinical Investigation|December 3, 1999
Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertensionP van Paassen, G J Navis, P E De Jong, et al.
Pageof 23